Phase III data for novel telomerase inhibitor released
Currently, imetelstat is being reviewed by the FDA and EMA…
Currently, imetelstat is being reviewed by the FDA and EMA for the treatment of transfusion-dependent anaemia in adults with lower risk MDS.